West Pharmaceutical Services (WST) Announces Resignation of COO
More News related to WST
- West to Present at UBS Investor Conference
- West to Present at Jefferies Investor Conference
- West to Present at CJS Securities Investor Conference
- West Announces Intention to Elect Entire Board Annually
- West Announces First Quarter 2010 Dividend
More News related to Management Changes
- Adeona Pharma (AEN) Appoints James Kuo as CEO and President
- Cowen Group (COWN) to Integrate Businesses to Streamline Operations
West Pharmaceutical Services, Inc. (NYSE: WST) announced that the company's Chief Operating Officer Matthew T. Mullarkey has left the company by mutual agreement. Company President and former Chief Operating Officer Steven A. Ellers, 58, will defer his previously announced 2010 retirement in order to provide managerial continuity and support following Mr. Mullarkey's departure.
West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. [SM]
Related Categories
Management ChangesStocks Mentioned
+0.62Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
